Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | deep value · medium |
| Evidence | 7/8 load-bearing inputs sourced — missing: Capex |
| Triangulated fair value | $92.80 (-8% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $97.83 (-3% vs spot · 12m PWEV) |
| Primary thesis-break | Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · deep value · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $101 |
| Triangulated Fair Value | $92.80 (-8% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $97.83 (-3% vs spot · 12m PWEV) |
| Forward P/E | 9.3x |
| Market Cap | $6B |
| 52-Week Range | $93.62–$132 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — an intrinsic DCF, a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-09-08. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 53.4/100 (33rd pct) | -3% 1yr expected | Hold | Covered Call | — |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $92.80 (-8% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.
Investment Thesis
Ingredion buys agricultural raw material, processes it, and sells starches and sweeteners into food and industrial customers. The economics are a spread business: volumes are relatively stable because the products are inputs to staples, while the gap between input cost and selling price is not, and that spread is where nearly all the earnings variance lives. At $101 on 9 September 2026 the shares are fairly valued against the engine's triangulated value (-8%), on 9 times forward earnings, nearer the bottom of the 52-week range than the top, with a margin near 12% and net debt of ~$0.9B. A single-digit multiple on a processor is not automatically cheap; it is the market's way of saying the current spread is not the through-cycle spread. The decisive question is therefore where processing margins sit relative to mid-cycle right now — the engine's base case assumes mid-cycle, its structural case assumes a reset. The most damaging risk is that pricing won during a tight period is competed away while the crop and energy costs that justified it do not fall as quickly.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($101) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The bear case is the classic trap in a spread business: earnings look best and the multiple looks lowest at exactly the wrong moment. If processing margins normalise downward, the denominator behind 9 shrinks, and a stock that appeared to trade on a single-digit multiple turns out to have been trading on a mid-teens multiple of normalised earnings all along. The mechanism is contractual as well as commodity: selling prices are negotiated on annual cycles, so when input costs fall the customer asks for the benefit immediately, and when they rise the pass-through arrives late. Capacity added across the industry during a profitable stretch arrives in the weak one. Meanwhile net debt of ~$0.9B and a dividend the market treats as fixed limit how much the balance sheet can absorb before capital allocation has to change. The engine's structural reset lands below the 52-week low.
Key Debate
Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.
What the Market Is Pricing In
At the current price, the market pays 9.5× consensus forward EPS, vs the house DCF terminal 8.0×, and a peer median 10.7×. The house DCF sits 10% below spot, so the market is pricing in more than the house case — roughly 1.5pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily multiple-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 7.2 | 7.3 | High |
| EPS | 10.6 | 10.9 | Medium |
| Target price | 121.5 | 97.8 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Crush / Protein Margin Reset' downside ($34.34) to a 'Spike — Supply Dislocation' bull case ($198); the probability-weighted blend (PWEV $97.83) is -3% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $34.34 | -66% |
| Cyclical Margin Trough | 18% | $61.14 | -39% |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $99.26 | -1% |
| Upcycle — Tight Margins | 20% | $158 | +57% |
| Spike — Supply Dislocation | 8% | $198 | +97% |
| Probability-Weighted (PWEV) | — | $97.83 | -3% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — free cash flow net of SBC is $0.51B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Crush / Protein Margin Reset (22%, $34.34). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Cyclical Margin Trough (18%, $61.14). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising.
- Base — Mid-Cycle Crush / Protein Margins (32%, $99.26). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns.
- Upcycle — Tight Margins (20%, $158). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly.
- Spike — Supply Dislocation (8%, $198). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins.
Valuation Triangulation
Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $89.18 | -11% | 20% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $72.87 | -28% | 0% — cross-check only |
| Scenario PWEV | multiple | $97.83 | -3% | 33% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $90.75 | -10% | 47% (declared 35%) |
| Triangulated (weighted) | — | $92.80 | -8% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $89.18 and 42% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (51% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 8.0x terminal FCF multiple → $90.75. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $72.87; the peer-median forward P/E is 10.7x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 28% of the median — moderate (healthy method disagreement — read the blend with care).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 5.6x | 6.8x | 8.0x | 9.2x | 10.4x |
|---|---|---|---|---|---|
| 7.0% | $79.00 | $89.05 | $99.11 | $109 | $119 |
| 8.0% | $75.63 | $85.22 | $94.82 | $104 | $114 |
| 9.0% | $72.42 | $81.59 | $90.75 | $99.92 | $109 |
| 10.0% | $69.37 | $78.13 | $86.89 | $95.65 | $104 |
| 11.0% | $66.48 | $74.85 | $83.22 | $91.59 | $99.96 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $59.08 | $70.50 | $81.91 | $93.33 | $105 |
| -1.5pp | $61.96 | $74.10 | $86.24 | $98.37 | $111 |
| +0.0pp | $64.96 | $77.86 | $90.75 | $104 | $117 |
| +1.5pp | $68.08 | $81.78 | $95.47 | $109 | $123 |
| +3.0pp | $71.31 | $85.86 | $100 | $115 | $129 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $65.00 | $117 | $52.00 |
| Capex intensity ±15% | $81.00 | $101 | $20.00 |
| Terminal × ±15% | $82.00 | $100 | $18.00 |
| Revenue CAGR ±3pp | $82.00 | $100 | $18.00 |
| WACC ±1pp | $87.00 | $95.00 | $8.00 |
Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 9.0x)
| Multiple | 6.3x | 7.6x | 9.0x | 10.3x | 11.7x |
|---|---|---|---|---|---|
| SoP/share | $76.00 | $94.00 | $114 | $133 | $153 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| DAR | 14.8× | 2% | 8% | segment | 50% |
| PPC | 7.9× | 2% | 4% | direct | 100% |
| SFM | 13.5× | 5% | 9% | segment | 50% |
| ACI | 6.7× | 5% | 2% | segment | 50% |
Quality-weighted forward P/E: 10.1× (simple median 10.7×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $93.62–$132, centre $111 (+10% vs spot); spot sits at the 19th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $92.80 (-8% vs spot · triangulated FV) |
| Downside to bear case (Structural — Crush / Protein Margin Reset) | $34.34 (-66% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -9% |
| P(price > spot) — Monte Carlo | 42% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Spike — Supply Dislocation): $198.
Company Overview & Business Model
Ingredion Incorporated — CONSUMER DEFENSIVE · PACKAGED FOODS. Ingredion Incorporated, produces and sells starches and sweeteners for various industries. The company is headquartered in Westchester, Illinois.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Agricultural Products & Protein | 100% | +2% | 12% | ag-processing crush margins / protein cycle + commodity & feed costs |
Edge. Narrow moat — inferred from a 12% operating margin and the agricultural products & protein business model. Some pricing power / share stability; terminal multiple near the market.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Agricultural Products & Protein | $7.2B | 100% | 2% | 12% | $0.9B | 9.0x | 6% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | ag-processing crush margins / protein cycle + commodity & feed costs |
| net_debt_or_cash_b | -0.91 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.06 |
| div_yield | 0.0319 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | crush / protein margin reset |
| upside | tight crush / protein margins |
Industry Context — Consumer Staples — Ag
This name sits in the Consumer Staples — Ag cluster as a agricultural products & protein name. ag-processing crush margins / protein cycle + commodity & feed costs. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: DAR (agricultural products & protein) · INGR (agricultural products & protein)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Crush / Protein Margin Reset | not stated | 40% | 40% |
| Mid-Cycle — Normalised Margins | not stated | 32% | 32% |
| Tight-Margin Upcycle | not stated | 28% | 28% |
Mapping note: name-level 'Structural — Crush / Protein Margin Reset' (22%) + 'Cyclical Margin Trough' (18%) map to cluster Crush / Protein Margin Reset (40%); name-level 'Upcycle — Tight Margins' (20%) + 'Spike — Supply Dislocation' (8%) map to cluster Tight-Margin Upcycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Crush / Protein Margin Reset — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The Consumer Staples — Ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs. Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $0.8B — modestly levered |
| Net debt / EBITDA | 0.66x |
| Interest coverage (EBIT / interest) | 27.3x |
| Current ratio | 2.66x |
| Lease obligations | $0.2B |
| Cash & ST investments | $1.0B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $0.5B |
| Buybacks / dividends | $0.2B / $0.2B |
| Total shareholder yield | 6.9% |
| Payout as % of FCF | 85.1% |
| Reinvestment (capex / OCF) | 45.9% |
| Allocation stance | returns-heavy |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 7.1% |
| FCF conversion (FCF / net income) | 70.1% |
| FCF yield | 8.1% |
| Capex intensity (capex / revenue) | 6.0% |
| FCF − SBC (diagnostic) | $0.5B |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 130% — cash-backed.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.21 vs analyst floor +0.00 → delta +0.21 (n=21 mgmt / 15 Q&A; 12th pctile across the S&P book, z -1.2).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.21 | +0.00 | +0.21 |
| 2025Q4 | +0.28 | +0.23 | +0.05 |
| 2025Q3 | +0.16 | +0.00 | +0.16 |
| 2025Q2 | +0.35 | +0.13 | +0.22 |
News (last 365d, 486 articles): avg ticker sentiment +0.07 (bullish 20% / bearish 4%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $122 (+21% vs spot · street) |
| House target | $97.83 (-19.5% vs street) |
| Sell-side coverage | 7 analysts (SB 1 / B 1 / H 5 / S 0 / SS 0; net score 0.21) |
| Consensus FY EPS | $10.57 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $7.2B; house in-line (+1.3%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Forecast Track Record
- EPS surprise: beat 62% of the last 8 quarters; average surprise +4.6%.
- Prior-forecast backtest (19 snapshots, 2026-07-21→2026-09-03): directional hit-rate 84%; mean predicted -5.7% vs realised -2.9%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
4 catalysts in the next 90 days (of 12 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 7d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 9d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 35d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 49d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 91d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 100d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 140d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 189d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 191d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 231d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 273d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 282d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Crush / Protein Margin Reset | Cluster state Crush / Protein Margin Reset — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Cyclical Margin Trough | Cluster state Crush / Protein Margin Reset — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Base — Mid-Cycle Crush / Protein Margins | Cluster state Mid-Cycle — Normalised Margins — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Upcycle — Tight Margins | Cluster state Mid-Cycle — Normalised Margins — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
| Spike — Supply Dislocation | Cluster state Tight-Margin Upcycle — see the Industry Context table for the house probability | Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state. |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-2.85 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-2.85 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.21 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
129.5 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
0.94 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
1.15 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints). Sustained demand rollover breaks the base case toward the recession scenario.
- FY revenue ($B) < 7.25 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
- Probability-weighted fair value (PWEV) at the next re-run < 100.7 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $101; 52-week range $93.62–$132; engine rating HOLD; house target $97.83 (-3%). (source: Alpha Vantage 2026-09-08, 9 September 2026)
- INFERENCE: Triangulated FV $92.80 (-8% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
53.4/100 (confidence band 43.6–63.1), 33rd percentile of 893 covered names (as of 2026-09-08). Weighted composite under config ros-1.20.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 54 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 80 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 47 | 15% | upside_pct |
| growth | 44 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 62 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 50 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 22 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | 78 | 10% | industry_context.house |
| risk profile | 46 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Score history: 56.0 → 56.1 → 56.0 → 55.8 → 55.9 → 56.1 → 53.6 → 53.7.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $34.34 | -65.9% | -14.5pp |
| Cyclical Margin Trough | 18% | $61.14 | -39.3% | -7.1pp |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $99.26 | -1.4% | -0.5pp |
| Upcycle — Tight Margins | 20% | $158 | +57.2% | +11.4pp |
| Spike — Supply Dislocation | 8% | $198 | +96.6% | +7.7pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | -2.9% |
| Expected return net of SBC dilution | -2.9% |
| Outcome dispersion (σ, from MC p10–p90) | 54.5% |
| Expected Sharpe (rf 4%) | -0.13 |
| Downside expectation (prob-weighted loss branches) | -22.0% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | -2.9% |
| Risk-free rate | 4.12% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-09-03) |
| Beta (shrunk, 1y vs SPY) | 0.40 (as of 2026-09-08) |
| Equity risk premium | 4.5% |
| Size/liquidity premium | +100bp |
| Required return | 6.9% |
| Expected alpha | -9.8% |
| Alpha per unit risk (EA/σ) | -0.18 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 51.3% (1σ) | 17.7% implied | our scenarios are far wider than the options market prices |
| Mass above spot: scenarios vs our own MC | 28.0% | 42.4% | the two expressions of our own view agree |
| Realised scenario frequency | 34 dated anchors | — | 34 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $97.83.
Flagged for review: scenario spread vs the options market. A flag marks a disagreement worth understanding — it does not imply either side is wrong.
Factor Exposures
Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 1 | AI | 26 | |
| Value | 72 | Cloud | 31 | |
| Quality | 60 | Semis | 25 | |
| Momentum | 27 | Consumer | 24 | |
| Low-Vol | 89 | Rates | 32 | |
| USD | 56 | |||
| Energy | 86 |
Market interaction: correlation vs SPY +0.22, vs QQQ +0.11 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
- Direction neutral from the overlay conviction/rating (read-only input).
- IV/RV at the 74th percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 58th percentile of its own month-end history (decile 6). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +3.0pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +3.0pp): 38-DTE 24% · 129-DTE 27% · 220-DTE 27%
| Priced structure | Value |
|---|---|
| Legs | Short 110 C |
| Expiry | 2026-10-16 |
| Income yield | 0.3% |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.30% NAV |
| Annualized outcome σ (MC) | 54.5% |
| Indicative holding period | 6–18 months |
| Liquidity | medium, ~$60M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-09-08 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 23.9% (elevated regime) · expected move ±5.7% (2026-10-16) · put/call OI 1.16 · ATM Δ 0.58 / Θ -0.04 / ν 0.13. Direction: NEUTRAL (implied return -7.8% to triangulated fair value $92.8).
Covered Call (if held) (Income / neutral) — Short 110 C · 2026-10-16 · premium $0.33 · yield 0.3% · priced from the listed chain (EOD marks)
Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Elevated implied volatility currently enriches the premium collected. Illustrative — no outcome is implied or guaranteed.
Put Spread (income) (Income / would-own) — Short 95 P / Long 85 P · 2026-10-16 · net $1.47 · net entry $93.53 · yield 1.5% · RoR 17.0% · max loss $8.54 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Protective Collar (if held) (Hedge) — Long 90 P / Short 110 C · 2027-04-16 · net $1.3 · floor -11.0% · cap +9.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -3% vs spot
- Monte Carlo median implies -11% vs spot
- DCF fair value implies -10% vs spot — but this is terminal-value sensitive (exit-multiple $90.75 vs Gordon $150, 65% apart), so it carries less weight
- Bear case (Structural — Crush / Protein Margin Reset) downside is -66% vs spot
- Net: the valuation anchor itself sits 7.8% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+2 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+3 | $8B | $1B | $0B | $0B | $1B | $1B |
| FY+4 | $8B | $1B | $0B | $0B | $1B | $1B |
| FY+5 | $8B | $1B | $0B | $0B | $1B | $0B |
| Terminal | — | — | — | — | $1B × 8.0x | $4B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $3B + PV(terminal) $4B = EV $7B; − net debt $0.9B → equity $6B ÷ diluted shares $0.06B = $90.75/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $150/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 3% vs WACC 9.0% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| DAR | 2.3x | 14.8x | 2% | 8% |
| PPC | 0.5x | 7.9x | 2% | 4% |
| SFM | 1.0x | 13.5x | 5% | 9% |
| ACI | 0.3x | 6.7x | 5% | 2% |
| Median | 0.8x | 10.7x | — | — |
Implied prices at the peer medians: EV/Rev → $72.87 (no P/E-implied price — no forward-EPS basis at the peer step).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $90.75 | 47% | $42.35 |
| Scenario PWEV | $97.83 | 33% | $32.61 |
| Monte Carlo median | $89.18 | 20% | $17.84 |
| Triangulated | — | 100% | $92.80 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 9.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 8× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (52.0); Capex intensity ±15% (20.0); Terminal × ±15% (18.0); Revenue CAGR ±3pp (18.0); WACC ±1pp (8.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $7.2B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $7.3B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $10.5665 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.063B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $0.757B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 9.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 8× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.20.0 |
| Analysis as-of | 2026-09-09 (prices 2026-09-08) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 7/8 load-bearing inputs sourced; 11/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 9.0%, terminal multiple 8×, FY+5 revenue $8B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-09-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-09-08 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-09-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-09-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-09-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-09-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-09-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-09-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-09-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-09-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-09-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-09-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 11/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.